These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 28398139)

  • 1. The association between high on-treatment platelet reactivity and early recurrence of ischemic events after minor stroke or TIA.
    Rao Z; Zheng H; Wang F; Wang A; Liu L; Dong K; Zhao X; Wang Y; Cao Y
    Neurol Res; 2017 Aug; 39(8):719-726. PubMed ID: 28398139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High On-Treatment Platelet Reactivity to Adenosine Diphosphate Predicts Ischemic Events of Minor Stroke and Transient Ischemic Attack.
    Rao Z; Zheng H; Wang F; Wang A; Liu L; Dong K; Zhao X; Cao Y; Wang Y
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2074-2081. PubMed ID: 28736132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between platelet function and recurrent ischemic vascular events after TIA and minor stroke
.
    Zhang J; Zhang J; Sun H; Ming T; Liu X; Cong Y; Li F; Li Z
    Int J Clin Pharmacol Ther; 2017 Oct; 55(10):789-797. PubMed ID: 28766499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary Stroke Prophylaxis with Clopidogrel Produces Sufficient Antiplatelet Response.
    Rath CL; Jørgensen NR; Wienecke T
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2683-2690. PubMed ID: 29945766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High on treatment platelet reactivity to aspirin and clopidogrel in ischemic stroke: A systematic review and meta-analysis.
    Fiolaki A; Katsanos AH; Kyritsis AP; Papadaki S; Kosmidou M; Moschonas IC; Tselepis AD; Giannopoulos S
    J Neurol Sci; 2017 May; 376():112-116. PubMed ID: 28431593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High on-treatment platelet reactivity on commonly prescribed antiplatelet agents following transient ischaemic attack or ischaemic stroke: results from the Trinity Antiplatelet Responsiveness (TRAP) study.
    Tobin WO; Kinsella JA; Coughlan T; Collins DR; O'Neill D; Murphy RP; Egan B; Tierney S; Feeley TM; McCabe DJ
    Eur J Neurol; 2013 Feb; 20(2):344-52. PubMed ID: 22994699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High on-treatment platelet reactivity in patients with ischemic cerebrovascular disease: assessment of prevalence and stability over time using four platelet function tests.
    Jover E; Rodríguez JM; Bernal A; Arroyo AB; Iniesta JA; Guiú IS; Martínez C; Vicente V; Lozano ML; Rivera J
    Blood Coagul Fibrinolysis; 2014 Sep; 25(6):604-11. PubMed ID: 24717421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ticagrelor versus clopidogrel on platelet reactivity measured by thrombelastography in patients with minor stroke or TIA.
    Yang Y; Chen W; Pan Y; Yan H; Meng X; Liu L; Wang Y; Wang Y
    Aging (Albany NY); 2020 Oct; 12(20):20085-20094. PubMed ID: 33065552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease.
    Hoh BL; Gong Y; McDonough CW; Waters MF; Royster AJ; Sheehan TO; Burkley B; Langaee TY; Mocco J; Zuckerman SL; Mummareddy N; Stephens ML; Ingram C; Shaffer CM; Denny JC; Brilliant MH; Kitchner TE; Linneman JG; Roden DM; Johnson JA
    J Neurosurg; 2016 Jun; 124(6):1746-51. PubMed ID: 26587656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet function/reactivity testing and prediction of risk of recurrent vascular events and outcomes after TIA or ischaemic stroke: systematic review and meta-analysis.
    Lim ST; Thijs V; Murphy SJX; Fernandez-Cadenas I; Montaner J; Offiah C; Marquardt L; Kelly PJ; Bath PM; Lim SY; Ford GA; Norrving B; Cox D; Prodan CI; Barber PA; Werring DJ; Perry R; Zgaga L; Dawson J; McCabe DJH
    J Neurol; 2020 Oct; 267(10):3021-3037. PubMed ID: 32518978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial.
    Pan Y; Chen W; Wang Y; Li H; Johnston SC; Simon T; Zhao X; Liu L; Wang D; Meng X; Wang Y;
    JAMA Neurol; 2019 May; 76(5):552-560. PubMed ID: 30742211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ticagrelor Aspirin vs Clopidogrel Aspirin in
    Wang A; Meng X; Tian X; Zuo Y; Bath PM; Li H; Xie X; Jing J; Lin J; Wang Y; Zhao X; Liu L; Li Z; Jiang Y; Xu J; Wang F; Chen W; Cao M; Li J; Wang Y
    Neurology; 2023 Jan; 100(5):e497-e504. PubMed ID: 36535779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of clopidogrel high on-treatment reactivity with clinical outcomes and gene polymorphism in acute ischemic stroke patients: An observational study.
    Fu H; Hu P; Ma C; Peng F; He Z
    Medicine (Baltimore); 2020 Apr; 99(15):e19472. PubMed ID: 32282698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High on-treatment platelet reactivity is associated with poor outcomes after ischemic stroke: A meta-analysis.
    Zhou K; Yu S; Li J; Tan Y; Xing S; Chen Y; Ouyang F; Zeng J; Zhang J
    Acta Neurol Scand; 2022 Sep; 146(3):205-224. PubMed ID: 35652290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet function testing in transient ischaemic attack and ischaemic stroke: A comprehensive systematic review of the literature.
    Lim ST; Coughlan CA; Murphy SJ; Fernandez-Cadenas I; Montaner J; Thijs V; Marquardt L; McCabe DJ
    Platelets; 2015; 26(5):402-12. PubMed ID: 26042726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High On-Treatment Platelet Reactivity as Predictor of Long-term Clinical Outcomes in Stroke Patients with Antiplatelet Agents.
    Lv H; Yang Z; Wu H; Liu M; Mao X; Liu X; Ding H; Shi Z; Zhou Y; Liu Q; Zhang Y; Zhou Y; Chen K; Li Z; Dong Q; Ma J; Han Y
    Transl Stroke Res; 2022 Jun; 13(3):391-398. PubMed ID: 34596891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack.
    Wang Y; Zhao X; Lin J; Li H; Johnston SC; Lin Y; Pan Y; Liu L; Wang D; Wang C; Meng X; Xu J; Wang Y;
    JAMA; 2016 Jul; 316(1):70-8. PubMed ID: 27348249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy.
    Wu Y; Zhou Y; Pan Y; Zhao X; Liu L; Wang D; Wang C; Li H; Johnston SC; Meng X; Wang Y; Wang Y;
    Pharmacogenomics J; 2018 Dec; 18(6):713-720. PubMed ID: 29520080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clopidogrel high-on-treatment platelet reactivity in acute ischemic stroke patients.
    Meves SH; Schröder KD; Endres HG; Krogias C; Krüger JC; Neubauer H
    Thromb Res; 2014 Mar; 133(3):396-401. PubMed ID: 24406048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.